Medication Adherence: A Positive Story You Are Not Hearing
Pharmaceutical companies are spending more to help patients adhere to their therapeutic regimens – an almost universally recognized way to improve health outcomes and pharma’s bottom line. But an unclear legal and regulatory climate and poor understanding of the adherence problems it is trying to solve means industry isn’t trumpeting what could be one of its best health care value arguments.
You may also be interested in...
Research by the National Community Pharmacists Association found that synchronizing medication refills to a single day helps to improve medication adherence.
Big launches, clinical success in key therapeutic areas like cancer immunotherapy, and renewed interest in biotech from a broad investor base floated the biopharma world through 2013’s average year for FDA approvals, the rocky rollout of the Affordable Care Act, and increasing concern about drug prices.
While mobile apps could offer a way for pharma to generate data about patients as well as a way to market to them, developing a successful app from scratch is a challenge that may not be worth the investment. Rather, a recent Sanofi partnership with a data aggregator demonstrates how to leverage the existing app landscape.